Global Incidence and Mortality Rates of Stomach Cancer and the Human Development Index: an Ecological Study

  • Khazaei, Salman (Department of Educational Health, School of Public Health, Hamadan University of Medical Sciences) ;
  • Rezaeian, Shahab (Social Development & Health Promotion Research Center, Gonabad University of Medical Sciences) ;
  • Soheylizad, Mokhtar (Department of Educational Health, School of Public Health, Hamadan University of Medical Sciences) ;
  • Khazaei, Somayeh (Operating Room, Rafsanjan University of Medical Sciences) ;
  • Biderafsh, Azam (Department of Social Medicine, Qom University of Medical Sciences)
  • Published : 2016.06.01


Background: Stomach cancer (SC) is the second leading cause of cancer death with the rate of 10.4% in the world. The correlation between the incidence and mortality rates of SC and human development index (HDI) has not been globally determined. Therefore, this study aimed to determine the association between the incidence and mortality rates of SC and HDI in various regions. Materials and Methods: In this global ecological study, we used the data about the incidence and mortality rate of SC and HDI from the global cancer project and the United Nations Development Programme database, respectively. Results: In 2012, SCs were estimated to have affected a total of 951,594 individuals (crude rate: 13.5 per 100,000 individuals) with a male/female ratio of 1.97, and caused 723,073 deaths worldwide (crude rate: 10.2 per 100,000 individuals). There was a positive correlation between the HDI and both incidence (r=0.28, P<0.05) and mortality rates of SC (r=0.13, P = 0.1) in the world in 2012. Conclusions: The high incidence and mortality rates of SC in countries with high and very high HDI is remarkable which should be the top priority of interventions for global health policymakers. In addition, health programs should be provided to reduce the burden of this disease in the regions with high incidence and mortality rates of SC.


  1. Bray F, Jemal A, Grey N, et al (2012). Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol, 13, 790-801.
  2. Brenner H, Rothenbacher D, Arndt V (2009). Epidemiology of stomach cancer. Methods Mol Biol, 472, 467-77.
  3. Da Hu Q, Zhang Q, Chen W, et al (2013). Human development index is associated with mortality-to incidence ratios of gastrointestinal cancers. World J Gastroenterol, 19, 5261-70.
  4. Derakhshan MH, Liptrot S, Paul J, et al (2009). Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut, 58, 16-23.
  5. Di Pardo BJ, Bronson NW, Diggs BS, et al (2016). The Global Burden of Esophageal Cancer: A Disability-Adjusted Life- Year Approach. World J Surg, 40, 395-401.
  6. Guo Y, Zeng H, Zheng R, et al (2016). The association between lung cancer incidence and ambient air pollution in China: A spatiotemporal analysis. Environ Res, 144, 60-5.
  7. Jemal A, Center MM, DeSantis C, et al (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907.
  8. Khazaei S, Rezaeian S, Khazaei Z, et al (2016). National breast cancer mortality and incidence rates according to the human development index: an ecological Study. Adv Breast Cancer Res, 5, 30-6.
  9. Kiadaliri AA (2014). Gender and social disparities in esophagus cancer incidence in Iran, 2003-2009: a time trend provincelevel study. Asian Pac J Cancer Prev, 15, 623-7.
  10. La Vecchia C (2016). Ovarian cancer: epidemiology and risk factors. Eur J Cancer Prev, [epub ahead of print].
  11. Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, et al (2015). The incidence and mortality of lung cancer and their relationship to development in Asia. Transl Lung Cancer Res, 4, 763-74.
  12. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
  13. Parkin DM, Bray FI, Devesa SS (2001). Cancer burden in the year 2000: the global picture. Eur J Cancer, 37, 4-66.
  14. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
  15. Uemura N, Okamoto S, Yamamoto S, et al (2001). Helicobacter pylori infection and the development of gastric cancer. N Engl J Med, 345, 784-9.
  16. Wang Z, Liu L, Ji J, et al (2012). ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci, 13, 13308-21.
  17. Yancik R (2005). Population aging and cancer: a cross-national concern. Cancer J, 11, 437-41.
  18. Youlden DR, Cramb SM, Baade PD (2008). The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol, 3, 819-31.
  19. Zhang X, Yan Y, Li S, et al (2015). Cancer burden in China from 2006 to 2010. Int J Clin Exp Pathol, 8, 13323-30.

Cited by

  1. A guide to multimodal endoscopy imaging for gastrointestinal malignancy — an early indicator vol.14, pp.7, 2017,
  2. Low expression of hsa_circ_0006633 in human gastric cancer and its clinical significances vol.39, pp.6, 2017,
  3. Chronic Periodontal Disease, Periodontal Pathogen Colonization, and Increased Risk of Precancerous Gastric Lesions vol.88, pp.11, 2017,
  4. The Relationship Between Human Development Index and Its Components with Thyroid Cancer Incidence and Mortality: Using the Decomposition Approach vol.In Press, pp.In Press, 2018,
  5. The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer vol.39, pp.1, 2018,